1. Home
  2. CNTA vs NATL Comparison

CNTA vs NATL Comparison

Compare CNTA & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • NATL
  • Stock Information
  • Founded
  • CNTA 2020
  • NATL 2023
  • Country
  • CNTA United Kingdom
  • NATL United States
  • Employees
  • CNTA N/A
  • NATL N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • NATL
  • Sector
  • CNTA Health Care
  • NATL
  • Exchange
  • CNTA Nasdaq
  • NATL Nasdaq
  • Market Cap
  • CNTA 2.3B
  • NATL 2.0B
  • IPO Year
  • CNTA 2021
  • NATL N/A
  • Fundamental
  • Price
  • CNTA $17.16
  • NATL $32.27
  • Analyst Decision
  • CNTA Strong Buy
  • NATL Buy
  • Analyst Count
  • CNTA 7
  • NATL 4
  • Target Price
  • CNTA $23.71
  • NATL $35.50
  • AVG Volume (30 Days)
  • CNTA 705.7K
  • NATL 614.7K
  • Earning Date
  • CNTA 11-12-2024
  • NATL 02-12-2025
  • Dividend Yield
  • CNTA N/A
  • NATL N/A
  • EPS Growth
  • CNTA N/A
  • NATL N/A
  • EPS
  • CNTA N/A
  • NATL N/A
  • Revenue
  • CNTA $6,853,000.00
  • NATL $4,307,000,000.00
  • Revenue This Year
  • CNTA N/A
  • NATL $4.77
  • Revenue Next Year
  • CNTA N/A
  • NATL $2.28
  • P/E Ratio
  • CNTA N/A
  • NATL N/A
  • Revenue Growth
  • CNTA N/A
  • NATL 3.58
  • 52 Week Low
  • CNTA $6.65
  • NATL $18.42
  • 52 Week High
  • CNTA $18.97
  • NATL $35.29
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 50.89
  • NATL 51.51
  • Support Level
  • CNTA $16.02
  • NATL $33.13
  • Resistance Level
  • CNTA $18.12
  • NATL $34.85
  • Average True Range (ATR)
  • CNTA 1.08
  • NATL 1.24
  • MACD
  • CNTA -0.08
  • NATL -0.36
  • Stochastic Oscillator
  • CNTA 41.42
  • NATL 30.46

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a global customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. They manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications & Technology.

Share on Social Networks: